BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12912959)

  • 1. beta-Catenin and ras oncogenes detect most human colorectal cancer.
    Zhang B; Ougolkov A; Yamashita K; Takahashi Y; Mai M; Minamoto T
    Clin Cancer Res; 2003 Aug; 9(8):3073-9. PubMed ID: 12912959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.
    Wong NA; Morris RG; McCondochie A; Bader S; Jodrell DI; Harrison DJ
    J Pathol; 2002 May; 197(1):128-35. PubMed ID: 12081197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
    Ougolkov AV; Yamashita K; Mai M; Minamoto T
    Gastroenterology; 2002 Jan; 122(1):60-71. PubMed ID: 11781281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
    Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
    Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
    Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
    Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
    Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
    Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.
    Seidler HB; Utsuyama M; Nagaoka S; Takemura T; Kitagawa M; Hirokawa K
    Exp Mol Pathol; 2004 Jun; 76(3):224-33. PubMed ID: 15126105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
    Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
    Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
    Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
    J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different genetic features associated with colon and rectal carcinogenesis.
    Frattini M; Balestra D; Suardi S; Oggionni M; Alberici P; Radice P; Costa A; Daidone MG; Leo E; Pilotti S; Bertario L; Pierotti MA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4015-21. PubMed ID: 15217933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling.
    Minamoto T; Ougolkov AV; Mai M
    Expert Rev Mol Diagn; 2002 Nov; 2(6):565-75. PubMed ID: 12465453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma.
    Kohya N; Kitajima Y; Kitahara K; Miyazaki K
    Int J Mol Med; 2003 Jan; 11(1):65-9. PubMed ID: 12469220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
    Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
    Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer.
    Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
    Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.